Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Servier

Servier and n-Lorem Foundation join forces to advance research in rare neurodevelopmental disorders

SURESNES, France and SAN DIEGO, June 10, 2026 /PRNewswire/ -- Servier, an independent international pharmaceutical company governed by a foundation, and n-Lorem Foundation, a non-profit organization established to charitably provide experimental medicines to treat nano-rare patients with high unmet needs, are entering into a multi-target research collaboration to develop antisense…

AAP · Jun 10

Servier to Acquire Edgewise Therapeutics' Muscular Dystrophy Business

SURESNES, France, June 1, 2026 /PRNewswire/ -- Servier, an independent international pharmaceutical group governed by a foundation, today announced that it has entered into an agreement to acquire the muscular dystrophy business of Edgewise Therapeutics Inc. (Nasdaq: EWTX), a biopharmaceutical company focused on developing innovative therapies for serious muscle disorders,…

AAP · Jun 1

IDEAYA Biosciences Eyes Busy 2026 as Darovasertib Advances Toward FDA Filing

IDEAYA Biosciences (NASDAQ:IDYA) Chief Executive Yujiro Hata said the precision oncology company is preparing for a busy 2026, led by regulatory and clinical milestones for darovasertib in metastatic uveal melanoma and multiple data readouts across its pipeline. Speaking at a Stifel-hosted event, H

MarketBeat · May 25

From analysis to the latest developments in health,
read the most diverse news in one place.

Biogaran sale talks renew fears over foreign control of French pharma

France’s top generic drug maker, Biogaran, could soon be sold to a British investment fund, raising new fears about the country’s control over vital medicines.

Radio France Internationale · Aug 4, 2025

‘These patients do not have time’: families in UK demand access to new drug that slows brain tumours

Vorasidenib worked in trials but is not yet available on the NHS

The Guardian - UK · Sep 17, 2023

New trials show increased survival rates for a range of cancers

A roundup of some of the most promising announcements at a meeting of the American Society of Clinical Oncology.

Al Jazeera · Jun 6, 2023

French pharmaceutical company appeals conviction over weight-loss drug

The drug company Servier on Monday launched an appeal in a Paris court against an earlier decision in the so-called Mediator affair. The group was heavily fined in 2021 for aggravated fraud and involuntary manslaughter in the production and marketing of a slimming drug.

Radio France Internationale · Jan 9, 2023

Read news from The Economist, FT, and more,
with one subscription

Coverage From

People

Dawn

276 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.